Showing 81 - 100 results of 214 for search '"statin"', query time: 0.05s Refine Results
  1. 81

    Analysis of Autoantibodies to 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Using Different Technologies by Lucile Musset, Makoto Miyara, Olivier Benveniste, Jean-Luc Charuel, Alexander Shikhman, Olivier Boyer, Richard Fowler, Andrew Mammen, Joe Phillips, Michael Mahler

    Published 2014-01-01
    “…Anti-HMGCR antibodies are not always associated with the use of statin and appear to be the exclusive autoantibody specificity in patients with statin associated myopathies.…”
    Get full text
    Article
  2. 82

    The Association between KIF6 Single Nucleotide Polymorphism rs20455 and Serum Lipids in Filipino-American Women by Irma B. Ancheta, Cynthia A. Battie, Dan Richard, Christine V. Ancheta, Nancy Borja-Hart, Annabelle S. Volgman, Yvette Conley

    Published 2014-01-01
    “…However, those with the Arg/Arg genotype on statin medication exhibited a significantly higher mean triglycerides level (P<0.01). …”
    Get full text
    Article
  3. 83

    Non-HDL-c/TC: A Novel Lipid-Related Marker in the Assessment of Severity of Coronary Artery Lesions and Cardiovascular Outcomes by Anan Huang, Xin Qi, Liping Wei, Mingyin Zhang, Shiqi Zhou

    Published 2019-01-01
    “…Non-high-density lipoprotein cholesterol (non-HDL-c) predicts the severity of coronary artery lesions in patients not treated with statin. The association between non-HDL-c and severity of coronary artery lesions in patients treated with lipid-lowering therapy has been unknown. …”
    Get full text
    Article
  4. 84

    Assessing the impact of clinically relevant medicinal chemistry teaching: Learning gains from case study approach by Fernanda Domingues Lustoza, João Paulo S. Fernandes

    Published 2025-01-01
    “…A lecture containing pharmacological information on statins was delivered to the students from the control group. …”
    Get full text
    Article
  5. 85
  6. 86

    The Effects of Simvastatin on Proteinuria and Renal Function in Patients with Chronic Kidney Disease by Bancha Satirapoj, Anan Promrattanakun, Ouppatham Supasyndh, Panbuppa Choovichian

    Published 2015-01-01
    “…Current data suggests that statins might have beneficial effects on renal outcomes. …”
    Get full text
    Article
  7. 87
  8. 88

    Low-Density Lipoprotein Cholesterol Levels in Coronary Artery Disease Patients: Opportunities for Improvement by Gary J. Martin, Meron Teklu, Edwin Mandieka, Joe Feinglass

    Published 2022-01-01
    “…At follow-up, 87.8% of patients were prescribed a statin, 9.7% were on ezetimibe, and 0.5% were on a PCSK9 inhibitor. …”
    Get full text
    Article
  9. 89

    Clinical Effect of Revascularization Strategies and Pharmacologic Treatment on Long-Term Results in Patients with Advanced Peripheral Artery Disease with TASC C and D Femoropoplite... by Chiu-Yang Lee

    Published 2022-01-01
    “…Kaplan–Meier curve analyses of time-to-primary cumulative AFS showed that nondiabetes mellitus, mild PAD, and cilostazol and statin treatment were correlated with a superior 3-year AFS (log rank test, P=0.001, P<0.001, P=0.009, and P=0.044, respectively). …”
    Get full text
    Article
  10. 90
  11. 91

    Comparative effects of pravastatin and rosuvastatin on carbohydrate metabolism in an experimental diabetic rat model by Kaya Hacer Kayhan, Demirtas Berjan, Yokus Beran, Kesim Dilek Aygün, Tasdemir Ezel, Sermet Abdurrahman

    Published 2024-03-01
    “…Statin treatment may increase the risk of diabetes; there is insufficient data on how statins affect glucose regulation and glycemic control and the effects of statins on liver enzymes related to carbohydrate metabolism have not been fully studied. …”
    Get full text
    Article
  12. 92

    Almanac 2015: coronary artery disease by D. Shavelle

    Published 2016-05-01
    “…These include assessment of novel biomarkers and imaging methods for patients at risk for coronary artery disease, care of patients with ST-segment elevation myocardial infarction, a novel device to treat medical refractory angina, use of non-statin lipid-lowering agents, a better understanding of the risks and benefits of longterm dual antiplatelet therapy and the use of the newer antiplatelet agents. …”
    Get full text
    Article
  13. 93

    Residual Dyslipidemia Leads to Unfavorable Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention by Bin Que, Chunmei Wang, Hui Ai, Xinyong Zhang, Mei Wang, Shaoping Nie

    Published 2016-01-01
    “…The present study aimed to evaluate the prevalence and prognosis of residual lipid abnormalities in statin-treated acute coronary syndrome (ACS) patients after percutaneous coronary intervention (PCI). …”
    Get full text
    Article
  14. 94

    Impact of duration of treatments with metformin and sulfonylureas, individually or in combination, on diabetic retinopathy among newly diagnosed type 2 diabetic patients: a pooled... by Mansour Bahardoust, Yadollah Mehrabi, Farzad Hadaegh, Davood Khalili, Ali Delpisheh

    Published 2025-01-01
    “…The cumulative exposure to metformin, SUs, aspirin, statin, and anti-hypertensive medication was also determined using the same approach. …”
    Get full text
    Article
  15. 95

    Myopathy with Concurrent Tadalafil and Simvastatin by Maria Pia Gargante, Marco Vacante, Cristina Russo, Mariano Malaguarnera

    Published 2009-01-01
    “…A 48-year-old man, using statin, was admitted to hospital with progressive myalgia after consumption of tadalafil and simvastatin. …”
    Get full text
    Article
  16. 96

    Role of high-density lipoprotein cholesterol in health and diseases by Brijesh Yadav, Narayan Prasad

    Published 2021-01-01
    “…In this review, we have discussed the different property of high-density lipoprotein cholesterol, its function and factors influencing HDLc property in light of anti-inflammatory activity in rheumatoid arthritis and the role of cholesterol-lowering statin drug in enhancing the beneficial effect of high-density lipoprotein cholesterol in different cell types.…”
    Get full text
    Article
  17. 97

    Adolescent with Rhabdomyolysis due to Undiagnosed Hypothyroidism by Raquel Farias Moeller, Nassim Zecavati, Rosa Sherafat-Kazemzadeh, Shoshana Aleinikoff, Wolfgang Rennert

    Published 2011-01-01
    “…Exercise-induced rhabdomyolysis has been described in military recruits, trained athletes and daily runners. Statin use, quail ingestion, infection by Epstein-Barr virus (EBV), and hypothyroidism, though rare, are risk factors for the development of rhabdomyolysis. …”
    Get full text
    Article
  18. 98

    Pure White Cell Aplasia and Necrotizing Myositis by Peter Geon Kim, Joome Suh, Max W. Adelman, Kwadwo Oduro, Erik Williams, Andrew M. Brunner, David J. Kuter

    Published 2016-01-01
    “…These findings were associated with a recent course of azithromycin and her daily use of a statin. Myositis improved on prednisone but PWCA persisted. …”
    Get full text
    Article
  19. 99

    Rosuvastatin, Sildenafil and Their Combination in Monocrotaline-Induced Pulmonary Hypertension in Rat by Jasińska-Stroschein Magdalena, Owczarek Jacek, Wesołowska Anna, Orszulak-Michalak Daria

    Published 2014-09-01
    “…There is considerable interest in the pleiotropic effects of statins and their potential role in the treatment of pulmonary hypertension. …”
    Get full text
    Article
  20. 100

    MANAGEMENT OF TYPE 2 DIABETES by Maitham Abdallah Albajy, Dan Florin Mihailescu

    Published 2024-04-01
    “…While SGLT2 inhibitors and GLP1 agents offer cardiovascular benefits, they should complement, not replace, statin therapy and blood pressure control for effective cardiovascular risk reduction.…”
    Get full text
    Article